The role of antiviral treatment in acute hepatitis B

Yang Chih Cheng; Sheng Uei Fang; Cheng Tiong; Ching Ruey Hsieh; Horng Yuan Lou; Jean Dean Liu; Shiann Pan; Chun Chao Chang

The role of antiviral treatment in acute hepatitis B

Yang Chih Cheng, Sheng Uei Fang, Cheng Tiong, Ching Ruey Hsieh, Horng Yuan Lou, Jean Dean Liu, Shiann Pan, Chun Chao Chang

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Acute hepatitis B was decreasing after the policy of global hepatitis B virus (HBV) vaccination in Taiwan. However, sporadic cases of acute hepatitis B were still encountered in our daily practice. Non-vaccination, non-response or poor response to current hepatitis B vaccine may be the cause. In addition, immune-selected or antiviral selected mutant strain may also cause new HBV infection in post-vaccination era. Studies for acute hepatitis B are not as much as for chronic hepatitis B. What is the role of antiviral agent in treating acute hepatitis B? Articles involved antiviral treatments for acute hepatitis B were reviewed. These studies showed antiviral agent may be beneficial in severe acute hepatitis B. But antiviral agent may play no role for non-severe form because it may interfere normal immune reaction and also impair anti-HBs formation.

Original language	English
Pages (from-to)	99-105
Number of pages	7
Journal	Journal of Internal Medicine of Taiwan
Volume	22
Issue number	2
Publication status	Published - Apr 2011

ASJC Scopus subject areas

Internal Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{e47ea0f4b7bb49d98ef2319cc4716b71,

title = "The role of antiviral treatment in acute hepatitis B",

abstract = "Acute hepatitis B was decreasing after the policy of global hepatitis B virus (HBV) vaccination in Taiwan. However, sporadic cases of acute hepatitis B were still encountered in our daily practice. Non-vaccination, non-response or poor response to current hepatitis B vaccine may be the cause. In addition, immune-selected or antiviral selected mutant strain may also cause new HBV infection in post-vaccination era. Studies for acute hepatitis B are not as much as for chronic hepatitis B. What is the role of antiviral agent in treating acute hepatitis B? Articles involved antiviral treatments for acute hepatitis B were reviewed. These studies showed antiviral agent may be beneficial in severe acute hepatitis B. But antiviral agent may play no role for non-severe form because it may interfere normal immune reaction and also impair anti-HBs formation.",

author = "Cheng, {Yang Chih} and Fang, {Sheng Uei} and Cheng Tiong and Hsieh, {Ching Ruey} and Lou, {Horng Yuan} and Liu, {Jean Dean} and Shiann Pan and Chang, {Chun Chao}",

year = "2011",

month = apr,

language = "English",

volume = "22",

pages = "99--105",

journal = "Journal of Internal Medicine of Taiwan",

issn = "1016-7390",

publisher = "臺灣內科醫學會",

number = "2",

}

TY - JOUR

T1 - The role of antiviral treatment in acute hepatitis B

AU - Cheng, Yang Chih

AU - Fang, Sheng Uei

AU - Tiong, Cheng

AU - Hsieh, Ching Ruey

AU - Lou, Horng Yuan

AU - Liu, Jean Dean

AU - Pan, Shiann

AU - Chang, Chun Chao

PY - 2011/4

Y1 - 2011/4

N2 - Acute hepatitis B was decreasing after the policy of global hepatitis B virus (HBV) vaccination in Taiwan. However, sporadic cases of acute hepatitis B were still encountered in our daily practice. Non-vaccination, non-response or poor response to current hepatitis B vaccine may be the cause. In addition, immune-selected or antiviral selected mutant strain may also cause new HBV infection in post-vaccination era. Studies for acute hepatitis B are not as much as for chronic hepatitis B. What is the role of antiviral agent in treating acute hepatitis B? Articles involved antiviral treatments for acute hepatitis B were reviewed. These studies showed antiviral agent may be beneficial in severe acute hepatitis B. But antiviral agent may play no role for non-severe form because it may interfere normal immune reaction and also impair anti-HBs formation.

AB - Acute hepatitis B was decreasing after the policy of global hepatitis B virus (HBV) vaccination in Taiwan. However, sporadic cases of acute hepatitis B were still encountered in our daily practice. Non-vaccination, non-response or poor response to current hepatitis B vaccine may be the cause. In addition, immune-selected or antiviral selected mutant strain may also cause new HBV infection in post-vaccination era. Studies for acute hepatitis B are not as much as for chronic hepatitis B. What is the role of antiviral agent in treating acute hepatitis B? Articles involved antiviral treatments for acute hepatitis B were reviewed. These studies showed antiviral agent may be beneficial in severe acute hepatitis B. But antiviral agent may play no role for non-severe form because it may interfere normal immune reaction and also impair anti-HBs formation.

UR - http://www.scopus.com/inward/record.url?scp=79957712618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957712618&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:79957712618

SN - 1016-7390

VL - 22

SP - 99

EP - 105

JO - Journal of Internal Medicine of Taiwan

JF - Journal of Internal Medicine of Taiwan

IS - 2

ER -

The role of antiviral treatment in acute hepatitis B

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this